Immunotherapy in HCC-No rush despite the hype

Hepatology. 2022 Oct;76(4):906-908. doi: 10.1002/hep.32550. Epub 2022 May 19.

Authors

Bruno Sangro¹, Josepmaria Argemí¹

Affiliation

¹ Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain.

PMID: 35491442
DOI: 10.1002/hep.32550

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Hepatocellular* / therapy
Humans
Immunologic Factors
Immunotherapy
Liver Neoplasms* / therapy

Substances

Immunologic Factors